Mr. Cameron Chell of Draganfly reports
DRAGANFLY DRONES TO DELIVER NUGEN M.D.'S NEEDLE-FREE INJECTION DEVICES AND INSULIN IN UKRAINE
Draganfly Inc. has been selected by
Medical Devices Inc. to help provide drones and services for the delivery of Nugen's InsuJet needle-free injection devices, insulin and other crucial medical supplies to affected areas in Ukraine.
Founded in 2017, Nugen is an emerging specialty medical device company focused on developing and commercializing novel drug delivery technologies. The company commercializes Food and Drug Administration-cleared and CE-approved needle-free injection systems catering to a wide range of applications.
Revived Soldiers Ukraine
(RSU), a non-profit organization dedicated to providing aid to the people of Ukraine, Draganfly's North American-made medical response drones will be used to deliver Nugen's InsuJet needle-free injection devices, preloaded with insulin, to dangerous and hard-to-reach areas across Ukraine.
Nugen's initial donation will be 50 InsuJet needle-free injection devices and 5,000 needle-free disposable syringes filled with insulin. Each device can be safely used 5,000 times without the risk of needle-stick injury or cross-contamination. Nugen's InsuJet needle-free injection device has been approved by Health Canada and holds a CE Mark.
Draganfly recently announced that its first medical response drone was received by Iryna Vashchuk Discipio, president of RSU, and members of her staff, including pilots, at a facility in Poland on May 1, 2022. The drone was then transported to Ukraine, where the company's experienced pilots conducted virtual training with RSU's drone operators.
Draganfly's medical response drone is able to carry up to 35 pounds. When equipped with the company's temperature-managed medical response payload box, the drone can transport temperature-sensitive medical supplies, including insulin/medicines, blood, pharmaceuticals, vaccines, water and wound care kits. The innovative payload system on this type of drone ensures ease of access when top mounted and effective quick-release operations when bottom mounted.
In addition to donating three drone systems, Draganfly received an order for its medical response and search and rescue drones from Coldchain Delivery Systems for immediate deployment with RSU. The company will provide an initial combined total of 10 North American-made medical response and search and rescue drones. The total initial order size (subject to conditions) is up to 200 units.
recently reported that insulin in Ukraine is in high demand, particularly in conflict zones. According to the
International Diabetes Foundation, there are over 2.3 million people living with diabetes in Ukraine. Many are Type 1 diabetics that need daily doses of insulin to survive.
"There is an urgent need for insulin and other life-saving medical supplies across Ukraine. The combination of our medical response drones and Nugen's easy-to-use, needle-free injectors, preloaded with insulin, will ensure that RSU can provide diabetic Ukrainians with the aid they require," said Cameron Chell, president and chief executive officer of Draganfly.
"At Nugen M.D., we believe every individual should have the opportunity to receive health care that is respectful, safe and empowering. Since tragedy struck Ukraine, we have been looking for ways to help," said Michael Wright, president and chief executive officer of Nugen Medical Devices. "We are grateful to be working with Draganfly, Coldchain Delivery Systems and RSU to ensure Ukrainians in need have access to crucial medical supplies and equipment."
Draganfly is the creator of quality, cutting-edge drone solutions, software and artificial intelligence systems that revolutionize the way organizations can do business and service their stakeholders. Recognized as being at the forefront of technology for over 20 years, Draganfly is an award-winning industry leader serving the public safety, public health, mining, agriculture, industrial inspections, security, mapping and surveying markets. Draganfly is a company driven by passion, ingenuity, and the need to provide efficient solutions and first-class services to its customers around the world with the goal of saving time, money and lives.
About Nugen Medical Devices Inc.
Nugen's principal business is the development and commercialization of innovative needle-free injection devices and systems for the administration of subcutaneous medication.
It is developing products using needle-free drug delivery technology in several important fields including, but not limited to, anaphylaxis, diabetes, severe migraine, erectile dysfunction, chronic anemia, neutropenia, autoimmune rheumatoid arthritis, growth and fertility hormone, psoriasis, as well as DNA and conventional/pediatric vaccines.
We seek Safe Harbor.
© 2022 Canjex Publishing Ltd. All rights reserved.